Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure)

Circulation. 2017 May 23;135(21):2077-2080. doi: 10.1161/CIRCULATIONAHA.117.027773.

¹ From Duke Clinical Research Institute (K.S.P., S.J.L., M.A.G., A.F.H.) and Department of Medicine (K.S.P., A.F.H.), Duke University School of Medicine, Durham, NC; Stanford University School of Medicine, Palo Alto, CA (P.A.H.); Bluhm Cardiovascular Institute, Northwestern University, Chicago, IL (C.W.Y.); and Geffen School of Medicine at University of California at Los Angeles (G.C.F.).
² From Duke Clinical Research Institute (K.S.P., S.J.L., M.A.G., A.F.H.) and Department of Medicine (K.S.P., A.F.H.), Duke University School of Medicine, Durham, NC; Stanford University School of Medicine, Palo Alto, CA (P.A.H.); Bluhm Cardiovascular Institute, Northwestern University, Chicago, IL (C.W.Y.); and Geffen School of Medicine at University of California at Los Angeles (G.C.F.). [email protected].

No abstract available

Keywords: drugs; heart failure.

Publication types